Record overview
Status and phase
Status: COMPLETED
Phase: PHASE1, PHASE2
Sponsor: University of Michigan Rogel Cancer Center
Condition: Adenocarcinoma of the Pancreas
NCT02037230
Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.